GDF15 and atrial fibrillation: GDF-15 was also shown to be related to the risk of developing major bleedings in patients with atrial fibrillation on oral anticoagulants and in patients with acute coronary syndrome on dual antiplatelet therapy, respectively, but with inconsistent results for the relationship of GDF-15 with all-cause stroke (9–11, 27).